Chester County News and Community Website
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced that its AC3 Range™ Intra-Aortic Balloon Pump (IABP) has received FDA 510(k) clearance. Designed for seamless intra-aortic balloon pumping across various modes …
Teleflex Secures FDA Clearance for AC3 Range IABP, Enhancing Cardiac Patient Transport Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) revealed a significant development in mental healthcare, announcing that Evernorth Health Services, a subsidiary of The Cigna Group, has expanded its coverage of NeuroStar® …
Neuronetics Announces Expanded Coverage for NeuroStar TMS to Treat Adolescent Depression Read More
WILMINGTON, DE — AstraZeneca presented new data on TAGRISSO® (osimertinib) at the European Lung Cancer Congress (ELCC) 2025, reinforcing its role as a backbone therapy across treatment stages for epidermal growth …
AstraZeneca Showcases TAGRISSO’s Potential in EGFR-Mutated Lung Cancer at ELCC 2025 Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced the approval of Qfitlia (fitusiran), a treatment designed to prevent or reduce the frequency of bleeding episodes in …
FDA Approves Qfitlia: A Breakthrough Treatment Revolutionizing Hemophilia Care Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has released a series of announcements covering a wide range of initiatives and regulatory updates, reflecting the agency’s ongoing commitment …
FDA Unveils Key Updates on Rare Disease Advances, Food Safety, and Medical Innovations Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has granted Visby Medical marketing authorization for its Women’s Sexual Health Test, a groundbreaking diagnostic tool that allows at-home testing …
Revolution in Healthcare: FDA Greenlights First At-Home Test for Three Major STIs Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has shared promising preliminary results from its Ringer™ PBC IDE study, featured in a presentation at the CTO Plus Conference in New York. The …
Teleflex Reports Promising Preliminary Results for Ringer PBC Study Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage biopharmaceutical company, is set to showcase significant advancements in its treatments for Alzheimer’s disease (AD) and Parkinson’s disease (PD) at the …
Annovis Bio to Present Promising Data on Buntanetap at AD/PD™ 2025 Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has unveiled groundbreaking results from the CLEAR study, the first head-to-head randomized controlled trial comparing the UroLift™ System with Rezūm™ Water Vapor Therapy (WVTT) …
Study Highlights UroLift™ System’s Advantages Over Rezūm™ in Treating BPH Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has announced a series of critical updates this week, reflecting its ongoing commitment to advancing public health and medical safety. …
FDA Unveils Life-Changing Drug, Urgent Device Alert, and Revolutionary Tech to Protect Your Health Read More